Avalon Ventures, GlaxoSmithKline Team On Two New Startups
socalTECH
SEPTEMBER 23, 2014
San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.
Let's personalize your content